[mstock id="73007" asset="reed"] https://www.businesswire.com/news/home/20220728005143/en/Better-Therapeutics-Completes-Pivotal-Trial-of-BT-001-for-Type-2-Diabetes-and-Announces-Positive-Secondary-Endpoint-Results-Following-the-Earlier-Announcement-of-Positive-Primary-Endpoint-Results